Catalyst Health Economics Consultants

Nocturia

1. Cost of illness analysis of nocturia in Germany, Sweden, and the United Kingdom.

Presented at the 21st Annual International Meeting of the International Society of Pharmacoeconomics and Outcomes Research (ISPOR), Washington DC, May 2016

2. Annual direct and indirect costs attributable to nocturia in Germany, Sweden, and the UK.

Author: D Weidlich, FL Andersson, M Oelke, MJ Drake, AF Jonasson, JF Guest.
Source: Eur J Health Econ. 2016; 18(6): 761-771.

View Abstract


<<< Go Back

Catalyst Health Economics Consultants Ltd
© 1991 - 2018